Cargando…

The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression

BACKGROUND: Patients with hepatocellular carcinoma (HCC) have poor prognosis, especially in advanced stages. Targeted therapy is the main treatment for advanced HCC patients, but the optimal targets for HCC remain poorly understood. The main purpose of this study was to identify potential novel prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Zhongyuan, Wang, Jielong, Chen, Gang, Li, Dongliang, Cheng, Bianqiao, Lai, Yanhua, Wu, Zhixian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869145/ https://www.ncbi.nlm.nih.gov/pubmed/36698420 http://dx.doi.org/10.3389/fonc.2022.1081510

Ejemplares similares

Upregulated hsa_circ_0005785 Facilitates Cell Growth and Metastasis of Hepatocellular Carcinoma Through the miR-578/APRIL Axis
por: Wu, Anqi, et al.
Publicado: (2020)

High mRNA Expression of CENPL and Its Significance in Prognosis of Hepatocellular Carcinoma Patients
por: Cui, Zhongyuan, et al.
Publicado: (2021)

MED10 Drives the Oncogenicity and Refractory Phenotype of Bladder Urothelial Carcinoma Through the Upregulation of hsa-miR-590
por: Wu, Chia-Chang, et al.
Publicado: (2022)

Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients
por: Cui, Zhongyuan, et al.
Publicado: (2022)

Correction: Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients
por: Cui, Zhongyuan, et al.
Publicado: (2023)

Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ji, Jia, et al.
Publicado: (2018)

hsa_circ_0129047 Upregulates LYVE1 to Inhibit Hepatocellular Carcinoma Progression by Sponging miR-492
por: Feng, Zhenzhen, et al.
Publicado: (2023)

HIPK3 Inhibition by Exosomal hsa-miR-101-3p Is Related to Metabolic Reprogramming in Colorectal Cancer
por: Tao, Lihuiping, et al.
Publicado: (2022)

Hsa_circ_0107593 Suppresses the Progression of Cervical Cancer via Sponging hsa-miR-20a-5p/93-5p/106b-5p
por: Liao, Wenyan, et al.
Publicado: (2021)

Exosomal hsa-miR199a-3p Promotes Proliferation and Migration in Neuroblastoma
por: Ma, Jing, et al.
Publicado: (2019)

Knockdown of hsa_circ_0023028 inhibits cell proliferation, migration, and invasion in laryngeal cancer by sponging miR-194-5p
por: Chen, Xiaofeng, et al.
Publicado: (2019)

Circular RNA CHST15 Sponges miR-155-5p and miR-194-5p to Promote the Immune Escape of Lung Cancer Cells Mediated by PD-L1
por: Yang, Jianru, et al.
Publicado: (2021)

Circular RNA hsa_circ_0013958 Functions as an Oncogenic Gene Through Modulating miR-532-3p/WEE1 Axis in Hepatocellular Carcinoma
por: Ma, Tao, et al.
Publicado: (2021)

Prognostic significance of miR-194 in endometrial cancer
por: Zhai, Haiyan, et al.
Publicado: (2013)

Upregulation of hsa_circ_0002003 promotes hepatocellular carcinoma progression
por: Zhou, Lisha, et al.
Publicado: (2023)

Autophagy Upregulates miR-449a Expression to Suppress Progression of Colorectal Cancer
por: Lan, Sheng-Hui, et al.
Publicado: (2021)

Radiosensitization effect of hsa-miR-138-2-3p on human laryngeal cancer stem cells
por: Zhu, Ying, et al.
Publicado: (2017)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)

Molecular Identification and In Silico Protein Analysis of a Novel BCOR-CLGN Gene Fusion in Intrathoracic BCOR-Rearranged Sarcoma
por: Chang Chien, Yi-Che, et al.
Publicado: (2023)

Circ-ZFR Promotes Progression of Bladder Cancer by Upregulating WNT5A Via Sponging miR-545 and miR-1270
por: Luo, Liping, et al.
Publicado: (2021)

Prognostic value of hsa-mir-299 and hsa-mir-7706 in hepatocellular carcinoma
por: Wang, Fenglin, et al.
Publicado: (2018)

Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients
por: Eldosoky, Mona A., et al.
Publicado: (2023)

circRPS16 Promotes Proliferation and Invasion of Hepatocellular Carcinoma by Sponging miR-876-5p to Upregulate SPINK1
por: Lin, Shuwen, et al.
Publicado: (2021)

Hsa_circ_0042823 accelerates cancer progression via miR-877-5p/FOXM1 axis in laryngeal squamous cell carcinoma
por: Wu, Tianyi, et al.
Publicado: (2021)

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
por: Montag, Judith, et al.
Publicado: (2009)

Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer
por: Zhao, Xin, et al.
Publicado: (2018)

Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients
por: Wang, Tongfei, et al.
Publicado: (2021)

Correlationship between Ki67, VEGF, and p53 and Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
por: Zhang, Xia, et al.
Publicado: (2021)

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
por: Zhang, Xia, et al.
Publicado: (2023)

miR-200a-3p- and miR-181-5p-Mediated HOXB5 Upregulation Promotes HCC Progression by Transcriptional Activation of EGFR
por: Li, Weizhi, et al.
Publicado: (2022)

Hsa_circ_0110757 upregulates ITGA1 to facilitate temozolomide resistance in glioma by suppressing hsa-miR-1298-5p
por: Li, Haoyu, et al.
Publicado: (2021)

Upregulation of miR-194-5p or silencing of PRC1 enhances radiotherapy sensitivity in esophageal squamous carcinoma cells
por: Wang, Yan, et al.
Publicado: (2023)

Identification of miR-203a, mir-10a, and miR-194 as predictors for risk of lymphovascular invasion in head and neck cancers
por: Karmakar, Moumita, et al.
Publicado: (2021)

miR194 hypomethylation regulates coronary artery disease pathogenesis
por: Duan, Lian, et al.
Publicado: (2022)

Up-Regulation of hsa_circ_0000517 Predicts Adverse Prognosis of Hepatocellular Carcinoma
por: Wang, Xicheng, et al.
Publicado: (2019)

Hsa_circ_0060927 Is a Novel Tumor Biomarker by Sponging miR-195-5p in the Malignant Transformation of OLK to OSCC
por: Xu, Siming, et al.
Publicado: (2022)

GFI1-Mediated Upregulation of LINC00675 as a ceRNA Restrains Hepatocellular Carcinoma Metastasis by Sponging miR-942-5p
por: Lu, Libai, et al.
Publicado: (2021)

Circulating hsa-miR-5096 predicts (18)F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors
por: Bocchini, Martine, et al.
Publicado: (2023)

Hsa_circ_0119412 is a tumor promoter in hepatocellular carcinoma by inhibiting miR-526b-5p to upregulate STMN1
por: Wu, Song, et al.
Publicado: (2023)

Upregulation of hsa_circ_0007874 suppresses the progression of ovarian cancer by regulating the miR‐760/SOCS3 pathway
por: Li, Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fagkhc4ekpmktts1l02d51hde4